HLA-B7: Protocol for a Phase I/II trial approved

Vical Inc. (VICL) Product: Vector and cytofectin liposome encoding HLA-B7 major histocompatibility complex protein Indication: Advanced colorectal carcinoma Status: Protocol for a Phase I/II trial de...